Comparison of Outcomes in Patients With Insulin-Dependent Versus Non-Insulin Dependent Diabetes Mellitus Receiving Drug-Eluting Stents (from the First Phase of the Prospective Multicenter German DES.DE Registry)

被引:24
作者
Akin, Ibrahim [1 ]
Bufe, Alexander [2 ]
Eckardt, Lars [3 ]
Reinecke, Holger [3 ]
Senges, Jochen [4 ]
Richardt, Gert [5 ]
Kuck, Karl-Heinz [6 ]
Schneider, Steffen [4 ]
Nienaber, Christoph A. [1 ]
机构
[1] Univ Hosp Rostock, Dept Internal Med 1, Rostock, Germany
[2] Wuppertal Univ Witten Herdecke, Dept Cardiol, Helios Clin, Herdecke, Germany
[3] Univ Hosp Munster, Dept Cardiol, Munster, Germany
[4] Inst Klin Kardiovaskulare Forsch, Ludwigshafen, Germany
[5] Heart Ctr Bad Segeberg, Dept Cardiol, Bad Segeberg, Germany
[6] Asklepios Hosp Hamburg, Dept Cardiol, Hamburg, Germany
关键词
CORONARY-HEART-DISEASE; CLINICAL-OUTCOMES; EUROPEAN-SOCIETY; POOLED ANALYSIS; TASK-FORCE; IMPACT; GUIDELINES; LESIONS; TERM;
D O I
10.1016/j.amjcard.2010.06.042
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Drug-eluting stents have been effective in randomized controlled trials, but their safety and efficacy in patients with insulin-dependent diabetes has not been well studied Baseline clinical and angiographic characteristics and in-hospital and follow-up events were recorded for enrolled patients From October 2005 and October 2006, 581 patients with insulin-dependent diabetes and 1,078 with non-insulin-dependent diabetes treated with sirolimus- and paclitaxel-eluting stents were enrolled at 98 sites The composite of death, myocardial infarction, and stroke, defined as major adverse cardiac and cerebrovascular events, as well as target vessel revascularization was used as the primary end point Multiple logistic regression analysis was used to adjust for confounding parameters Baseline clinical characteristics were more severe in patients with insulin-dependent diabetes, whereas descriptive characteristics were not unique At 1-year follow-up, the comparison between the 2 groups revealed significantly higher rates of overall death (7 4% vs 4 6%, p <0 05), target vessel revascularization (15 1% vs 10 4%, p <0 05), and overall stent thrombosis (6 5% vs 4 1%, p <0 05) for insulin-dependent patients, while rates of major adverse cardiac and cerebrovascular events were not significantly different (12 8% vs 9 9%, p = 0 09) These results persisted even after risk adjustment for heterogenous baseline characteristics of the 2 groups In conclusion, the data generated from the German Drug-Eluting Stent (DES DE) registry revealed that even with drug-eluting stents, the annual risk for death, target vessel revascularization, and thrombotic events remains higher in patients with insulin-dependent diabetes compared to those with non-insulin-dependent diabetes (C) 2010 Elsevier Inc All rights reserved (Am J Cardiol 2010,106 1201-1207)
引用
收藏
页码:1201 / 1207
页数:7
相关论文
共 30 条
[1]   The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation [J].
Abizaid, A ;
Kornowski, R ;
Mintz, GS ;
Hong, MK ;
Abizaid, AS ;
Mehran, R ;
Pichard, AD ;
Kent, KM ;
Satler, LF ;
Wu, HS ;
Popma, JJ ;
Leon, MB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (03) :584-589
[2]  
[Anonymous], 1999, Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO consultation
[3]   Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention [J].
Corpus, RA ;
George, PB ;
House, JA ;
Dixon, SR ;
Ajluni, SC ;
Devlin, WH ;
Timmis, GC ;
Balasubramaniam, M ;
O'Neill, WW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (01) :8-14
[4]   Clinical end points in coronary stent trials - A case for standardized definitions [J].
Cutlip, Donald E. ;
Windecker, Stephan ;
Mehran, Roxana ;
Boam, Ashley ;
Cohen, David J. ;
van Es, Gerrit-Anne ;
Steg, P. Gabriel ;
Morel, Marie-angele ;
Mauri, Laura ;
Vranckx, Pascal ;
McFadden, Eugene ;
Lansky, Alexandra ;
Hamon, Martial ;
Krucoff, Mitchell W. ;
Serruys, Patrick W. .
CIRCULATION, 2007, 115 (17) :2344-2351
[5]  
Daemen Joost, 2007, EuroIntervention, V3, P392, DOI 10.4244/EIJV3I3A70
[6]   The long-term value of sirolimus- and paclitaxel-eluting stents over bare metal stents in patients with diabetes mellitus [J].
Daemen, Joost ;
Garcia-Garcia, Hector M. ;
Kukreja, Neville ;
Imani, Farshad ;
de Jaegere, Peter P. T. ;
Sianos, Georgios ;
van Domburg, Ron T. ;
Serruys, Patrick W. .
EUROPEAN HEART JOURNAL, 2007, 28 (01) :26-32
[7]   Drug-eluting stent thrombosis -: Results from the Multicenter Spanish registry ESTROFA (Estudio ESpanol sobre TROmbosis de stents FArmacoactivos) [J].
de la Torre-Hernandez, Jos M. ;
Alfonso, Fernando ;
Hernandez, Felipe ;
Elizaga, Jaime ;
Sanmartin, Marcelo ;
Pinar, Eduardo ;
Lozano, Inigo ;
Vazquez, Jose M. ;
Botas, Javier ;
Perez de Prado, Armando ;
Hernandez, Jose M. ;
Sanchis, Juan ;
Ruiz Nodar, Juan M. ;
Gomez-Jaume, Alfredo ;
Larman, Mariano ;
Diarte, Jose A. ;
Rodriguez-Collado, Javier ;
Rumoroso, Jose R. ;
Lopez-Minguez, Jose R. ;
Mauri, Josepa .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) :986-990
[8]   Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients [J].
Dibra, A ;
Kastrati, A ;
Mehilli, J ;
Pache, J ;
Schühlen, H ;
von Beckerath, N ;
Ulm, K ;
Wessely, R ;
Dirschinger, J ;
Schömig, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (07) :663-670
[9]   Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement [J].
Elezi, S ;
Kastrati, A ;
Pache, J ;
Wehinger, A ;
Hadamitzky, M ;
Dirschinger, J ;
Neumann, FJ ;
Schömig, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (07) :1866-1873
[10]   Diabetes and coronary revascularization [J].
Flaherty, JD ;
Davidson, CJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (12) :1501-1508